Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Primary IgA-nephropathy”

72 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 72 results

Post-approval studies (Phase 4)UnknownNCT05824390
What this trial is testing

A Randomized, Controlled Clinical Study of Rituximab in Treatment of Primary IgA Nephropathy

Who this might be right for
IgA Nephropathy
XIEJINGYUAN 116
Early research (Phase 1)Study completedNCT05314231
What this trial is testing

Safety and Pharmacokinetic Study of Subcutaneous ALXN1720 in Participants With Proteinuria

Who this might be right for
Proteinuria
Alexion Pharmaceuticals, Inc. 13
Testing effectiveness (Phase 2)Looking for participantsNCT07582133
What this trial is testing

A Trial to Evaluate the Long-term Safety and Tolerability of HRS-5965 in Patients With Primary IgA Nephropathy

Who this might be right for
Primary IgA Nephropathy
Chengdu Suncadia Medicine Co., Ltd. 380
Testing effectiveness (Phase 2)Looking for participantsNCT07606352
What this trial is testing

Safety and Efficacy of STL303 In Patients With Primary Immunoglobulin A (IgA) Nephropathy

Who this might be right for
IgAN
Sitala Bio LTD 15
Not applicableLooking for participantsNCT07074951
What this trial is testing

Tonsillectomy and Immunosuppression in Caucasian Patients With High-risk IgA-nephropathy

Who this might be right for
Primary IgA-nephropathyHigh-riskCaucasians
St. Petersburg State Pavlov Medical University 240
Large-scale testing (Phase 3)Looking for participantsNCT07024563
What this trial is testing

Study of Ravulizumab in Pediatric Participants With Primary IgAN

Who this might be right for
IgANIgAVNImmunoglobulin A Nephropathy+3 more
Alexion Pharmaceuticals, Inc. 36
Post-approval studies (Phase 4)UnknownNCT02765594
What this trial is testing

Hydroxychloroquine Sulfate Alleviates Persistent Proteinuria in IgA Nephropathy

Who this might be right for
Primary IgA Nephropathy
Peking Union Medical College Hospital 98
Early research (Phase 1)Study completedNCT05174221
What this trial is testing

Mezagitamab in Adults With Primary Immunoglobulin A Nephropathy Receiving Stable Background Therapy

Who this might be right for
Kidney DiseaseGlomerulonephritis
Takeda 17
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06830395
What this trial is testing

Study of CM313 in Subject With IgA Nephropathy

Who this might be right for
IgA Nephropathy
Keymed Biosciences Co.Ltd 106
Testing effectiveness (Phase 2)Study completedNCT05016323
What this trial is testing

Evaluate the Efficacy and Safety of HR19042 Capsules in the Treatment of Primary IgA Nephropathy.

Who this might be right for
IgA Nephropathy
Jiangsu HengRui Medicine Co., Ltd. 316
Large-scale testing (Phase 3)Active Not RecruitingNCT05797610
What this trial is testing

Evaluate the Efficacy and Safety of Sefaxersen (RO7434656) in Participants With Primary Immunoglobulin A (IgA) Nephropathy at High Risk of Progression

Who this might be right for
Primary IgA Nephropathy
Hoffmann-La Roche 459
Post-approval studies (Phase 4)Study completedNCT04525729
What this trial is testing

Rituximab and RASi in Patients with IgAN

Who this might be right for
IgA Nephropathy
Nan Chen,MD 116
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07474636
What this trial is testing

Efficacy and Safety Study of HS-10542 for IgA Nephropathy

Who this might be right for
IgANImmunoglobulin A Nephropathy (IgAN)Glomerular Disease
Jiangsu Hansoh Pharmaceutical Co., Ltd. 90
Testing effectiveness (Phase 2)Active Not RecruitingNCT05732402
What this trial is testing

An Open-label Study of Povetacicept in Autoantibody-Associated Glomerular Diseases

Who this might be right for
Lupus NephritisImmunoglobulin A NephropathyMembranous Nephropathy+1 more
Alpine Immune Sciences, Inc. 72
Not applicableUnknownNCT02829164
What this trial is testing

Tonsillectomy and Primitive IgA Nephropathy in Children: Strasbourg Cohort and Assessment Practices in Inter North East Region

Who this might be right for
Tonsillectomy
University Hospital, Strasbourg, France 20
Testing effectiveness (Phase 2)Ended earlyNCT04905212
What this trial is testing

Telitacicept for Injection (RC18) in Subjects With IgA Nephropathy

Who this might be right for
IgA Nephropathy
RemeGen Co., Ltd. 15
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07553494
What this trial is testing

SLN12140 in Adult Participants With IgA Nephropathy in China

Who this might be right for
IgA Nephropathy (IgAN)
Linno Pharmaceuticals, Inc. 48
Not applicableLooking for participantsNCT06926244
What this trial is testing

RESistance of IgA Nephropathy to Conventional and Newly-approved Therapies: an Observational, Real-life Study (RESIGAN)

Who this might be right for
IgA Nephropathy (IgAN)
Assistance Publique - Hôpitaux de Paris 800
Post-approval studies (Phase 4)Looking for participantsNCT06712407
What this trial is testing

Efficacy and Safety of Extended TARPEYO® Treatment Beyond 9 Months in Adult Patients With Primary IgA Nephropathy

Who this might be right for
IgA Nephropathy
Calliditas Therapeutics AB 60
Post-approval studies (Phase 4)Looking for participantsNCT06676384
What this trial is testing

Which of the Commonly Available and Approved Drugs in Addition to Standard of Care Can Significantly Improve the Slope of Estimated Glomerular Filtration Rate at Two Years When Compared to Standard of Care Alone in South-Asian Kidney Biopsy-proven Adult (≥18 Years) Primary IgA Nephropathy?

Who this might be right for
IgA NephropathyRenal Insufficiency, ChronicIgA Vasculitis+1 more
Christian Medical College, Vellore, India 585
Next Page